España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Hoban Law Group
Benzinga Contributor
The DEA Doesn't Quite Get It, But Hemp Is Not The Same As Marijuana
This article was originally published on Hoban Law Group, and appears here with permission.
Will Marijuana Become Legal? Is Federalization Even What We Really Want?
This article was originally published on Hoban Law Group, and appears here with permission.
Why Was Hemp Made Ilegal? The Evolution Of Cannabis
This article was originally published on Hoban Law Group, and appears here with permission.
Weed: It's Not Legal, So It Must Be Dangerous - Right?
This article was originally published on Hoban Law Group, and appears here with permission. “Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse” – U.S. Controlled Substances Act
Marijuana CBD vs. Hemp CBD: What's The Difference?
This article was originally published on Hoban Law Group, and appears here with permission.
Rewriting The Cannabis Narrative In Colombia: Part 2
In 2016, Colombia passed a landmark framework regulating the production, distribution, sale, and export of seeds and other cannabis derivatives<
Rewriting The Cannabis Narrative In Colombia: Part 1
For decades, Colombia has borne the burden of America’s foreign drug policy. The public imagination has long been associated with the legacy of narco-trafficking violence perpetrated by Pablo Escobar, the Medellin cartel, and the Cali Cartel.
Apple Secretly Joined Amazon In Advancing Commercial Cannabis Reform
This past summer, a little recognized thing occurred — one of the largest and most respected companies in the world quietly changed its policies in favor of cannabis. That company was Apple (NASDAQ: AAPL).
Navigating The Wave Of U.S. Cannabis Investment
This article by Robert Hoban was originally published on Forbes and appears here with permission.
Delta-8 THC: A Tale Of American Ingenuity
This article by Robert Hoban was originally published on Forbes and appears here with permission.
Five Essential Tips For Labeling Hemp Products
This article was originally published on Hoban Law Group, and appears here with permission.
The NFL Steps Forward To Support Cannabis Research
This article by Robert Hoban was originally published on Forbes and appears here with permission.
State-Specific Hemp And Marijuana Product Labeling Requirements
This article was originally published on Hoban Law Group, and appears here with permission.
A Preview Of The Many Cannabis Intellectual Property Battles In Years To Come: New Leaf Data Services & The Supplemental Register Sneak Attack
This article was originally published on Hoban Law Group, and appears here with permission.
The Building Blocks Of A Mergers And Acquisitions Contract For A Cannabis Business
This article was originally published on Hoban Law Group, and appears here with permission.
Accounting For Cannabis Companies: An Expert Weighs In
This article was originally published on Hoban Law Group, and appears here with permission.
The Critical Importance Of Social Equity In The Cannabis Industry
This article by Robert Hoban was originally published on Forbes and appears here with permission.
What Happens When Cannabis Becomes A Commodity?
This article by Robert Hoban was originally published on Forbes and appears here with permission.
CBD Has Never Been A Controlled Substance
This article by Robert Hoban was originally published on Forbes and appears here with permission.
There's Still A Reason To Be Hyped About Industrial Hemp
This article by Robert Hoban was originally published on Forbes and appears here with permission.